Product
ACH-000029
1 clinical trial
1 indication
Indication
Healthy Control ParticipantsClinical trial
A Phase 1, Single-center, Placebo-controlled, Double-blind, Randomized Trial to Assess the Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of ACH-000029 in Healthy SubjectsStatus: Terminated, Estimated PCD: 2022-11-02